Planned early birth for pregnant women with high blood pressure cuts maternal complications by nearly half and reduces the risk of stillbirth, without increasing the likelihood of caesarean section, according to a new Cochrane review.

Scientists at La Jolla Institute for Immunology (LJI) have discovered that combining key vaccine ingredients could give the body the tools it needs to fight the entire family of arenaviruses with a single vaccine.

Critical Path Institute today announced the launch of the New Approach Methodologies Developer Coalition (NAMs-DC), a precompetitive, public-private initiative bringing together companies that develop new approach methodologies (NAMs) to accelerate their adoption, validation, and qualification as tools for drug discovery and development. The coalition formally launches ahead of the MPS World Summit, which convenes the global microphysiological systems community the week of May 25, 2026.

Healthcare has lost its human, moral, and relational foundations and must reconnect with its core values to improve both patient and staff well-being, argue experts in The BMJ today.

Critical Path Institute® today announced the award of a $249,719 research grant to Odylia Therapeutics, a nonprofit biotechnology organization based in Atlanta. The awarded program and Odylia are led by Ashley Winslow, Ph.D., CEO and Chief Scientific Officer. The award is part of C-Path’s Bridging Research and Innovation in Drug Development Grants (BRIDGe) program, offered through its Translational Therapeutics Accelerator.

When health policy researchers at the Brown University School of Public Health tracked data from primary care practices that had been acquired by private equity firms, they found something surprising: not all of the changes were detrimental.